Big Pharmaceuticals

---

June 21, 2024

Profit Over Patients: Insulin Pen Shortage in South Africa

South Africa is running out of insulin pens due to Novo Nordisk’s decision not to renew its contract, focusing instead on more profitable weight- loss drugs. The shift to vials represents a step backward in diabetes care. Vials and syringes are harder to use and less precise, raising concerns about medication adherence and long-term complications….

---